94 related articles for article (PubMed ID: 1425205)
1. The influence of seaprose on erythromycin penetration into bronchial mucus in bronchopulmonary infections.
Braga PC; Piatti G; Grasselli G; Casali W; Beghi G; Allegra L
Drugs Exp Clin Res; 1992; 18(3):105-11. PubMed ID: 1425205
[TBL] [Abstract][Full Text] [Related]
2. Effects of seaprose on the rheology of bronchial mucus in patients with chronic bronchitis. A double-blind study vs placebo.
Braga PC; Moretti M; Piacenza A; Montoli CC; Guffanti EE
Int J Clin Pharmacol Res; 1993; 13(3):179-85. PubMed ID: 8225701
[TBL] [Abstract][Full Text] [Related]
3. Effects of seaprose on sputum biochemical components in chronic bronchitic patients: a double-blind study vs placebo.
Moretti M; Bertoli E; Bulgarelli S; Testoni C; Guffanti EE; Marchioni CF; Braga PC
Int J Clin Pharmacol Res; 1993; 13(5):275-80. PubMed ID: 8200722
[TBL] [Abstract][Full Text] [Related]
4. Comparison between penetration of amoxicillin combined with carbocysteine and amoxicillin alone in pathological bronchial secretions and pulmonary tissue.
Braga PC; Scaglione F; Scarpazza G; Fraticelli G; Roviaro G; Varoli F; Mariani C; Falchi M; Fraschini F
Int J Clin Pharmacol Res; 1985; 5(5):331-40. PubMed ID: 4066083
[TBL] [Abstract][Full Text] [Related]
5. In vitro rheological assessment of mucolytic activity induced by seaprose.
Braga PC; Rampoldi C; Ornaghi A; Caminiti G; Beghi G; Allegra L
Pharmacol Res; 1990; 22(5):611-7. PubMed ID: 2277801
[TBL] [Abstract][Full Text] [Related]
6. Serum, sputum and bronchial concentrations of erythromycin in chronic bronchitis after single and multiple treatments with either propionate-N-acetylcysteinate or stearate erythromycin.
Ricevuti G; Pasotti D; Mazzone A; Gazzani G; Fregnan GB
Chemotherapy; 1988; 34(5):374-9. PubMed ID: 3180905
[TBL] [Abstract][Full Text] [Related]
7. [Effect of a secretolytic agent (bromhexine) on the penetration of erythromycin into bronchial secretions].
Bergogne-Berezin E; Pierre J; Dournovo P
Fortschr Med; 1982 Jun; 100(24):1169-71. PubMed ID: 7049878
[TBL] [Abstract][Full Text] [Related]
8. Rheological profile of nesosteine: a new mucoactive agent.
Braga PC; Beghi G; Castelli C; Grasselli G; Ornaghi A; Rampoldi C; Zheng Y; Allegra L
Int J Clin Pharmacol Res; 1989; 9(1):77-83. PubMed ID: 2707929
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and sputum levels of josamycin after single and multiple administrations in bronchopneumopathic patients.
Fraschini F; Braga PC; Biella G; Scaglione F; Montoli C; Scarpazza G
Int J Clin Pharmacol Res; 1983; 3(3):203-8. PubMed ID: 6679523
[TBL] [Abstract][Full Text] [Related]
10. [Penetration of mezlocillin into bronchial secretions (author's transl)].
Morel C; Benard Y; Vergnaud M; Langeard M
Nouv Presse Med; 1982 Feb; 11(5 Pt 2):365-7. PubMed ID: 6460977
[TBL] [Abstract][Full Text] [Related]
11. Influence of a fluidifying agent (bromhexine) on the penetration of antibiotics into respiratory secretions.
Bergogne-Bérézin E; Berthelot G; Kafé HP; Dournovo P
Int J Clin Pharmacol Res; 1985; 5(5):341-4. PubMed ID: 4066084
[TBL] [Abstract][Full Text] [Related]
12. Erythromycin and bromhexine in acute exacerbations of chronic bronchitis. A study on sputum penetration and clinical effectiveness.
Maesen FP; Davies BI; Brouwers J; Rubingh G
Eur J Respir Dis; 1982 Jul; 63(4):325-9. PubMed ID: 6981522
[TBL] [Abstract][Full Text] [Related]
13. Mucoactive agents for airway mucus hypersecretory diseases.
Rogers DF
Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
[TBL] [Abstract][Full Text] [Related]
14. Recent advances of knowledge on the mechanism of action of drugs modifying the bronchial secretions.
Morandini GC; Perduca M; Finiguerra M; De Martini S; Fraticelli G
Int J Clin Pharmacol Res; 1986; 6(5):415-23. PubMed ID: 3781704
[TBL] [Abstract][Full Text] [Related]
15. [The treatment of ENT phlogosis: seaprose S vs. nimesulide].
Antonelli A; Cimino A; Cimino A; Di Girolamo A; Filippi P; Filippin S; Galetti G; Marchiori C; Marcucci L; Mira E
Acta Otorhinolaryngol Ital; 1993; 13 Suppl 39():1-16. PubMed ID: 8135108
[TBL] [Abstract][Full Text] [Related]
16. [Diffusion of ciprofloxacin into bronchial secretions in mechanically ventilated patients].
Saux P; Martin C; Portet C; Bruguerolle B; Papazian L; Mallet MN; Gouin F
Pathol Biol (Paris); 1991 May; 39(5):515-9. PubMed ID: 1881686
[TBL] [Abstract][Full Text] [Related]
17. The pharmacologic approach to airway clearance: mucoactive agents.
Rubin BK
Respir Care; 2002 Jul; 47(7):818-22. PubMed ID: 12088552
[TBL] [Abstract][Full Text] [Related]
18. Comparison between sulbenicillin and piperacillin levels in serum and in bronchial secretions--a pharmacokinetic study.
Fraschini F; Scaglione F; Bichisao E; Marchi E; Scarpazza G; Scarpazza P; Gaffuri Riva V
Int J Clin Pharmacol Ther Toxicol; 1987 Nov; 25(11):638-42. PubMed ID: 3429068
[TBL] [Abstract][Full Text] [Related]
19. Rheological modifications of mucus in chronic bronchitic patients after treatment with stepronine-lysine salt.
Braga PC; Bossi R; Allegra L
Drugs Exp Clin Res; 1987; 13(11):707-10. PubMed ID: 3443046
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of penetration and clearance of mezlocillin in the bronchopulmonary tract.
Braga PC; Marchi E; Scaglione F; Scarpazza G; Faravelli M; Fraschini F
Int J Clin Pharmacol Res; 1984; 4(5):361-5. PubMed ID: 6519850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
